rs386134264
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The variant allele was found at a frequency of 0.000291 in 1,613,274 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0012 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
TRB
intragenic
intragenic
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.129
Genes affected
PRSS1 (HGNC:9475): (serine protease 1) This gene encodes a trypsinogen, which is a member of the trypsin family of serine proteases. This enzyme is secreted by the pancreas and cleaved to its active form in the small intestine. It is active on peptide linkages involving the carboxyl group of lysine or arginine. Mutations in this gene are associated with hereditary pancreatitis. This gene and several other trypsinogen genes are localized to the T cell receptor beta locus on chromosome 7. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 7-142749451-GTCC-G is Benign according to our data. Variant chr7-142749451-GTCC-G is described in ClinVar as [Likely_benign]. Clinvar id is 36703.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRSS1 | ENST00000311737.12 | c.-33_-31delTCC | upstream_gene_variant | 1 | NM_002769.5 | ENSP00000308720.7 | ||||
PRSS1 | ENST00000486171.5 | c.-33_-31delTCC | upstream_gene_variant | 5 | ENSP00000417854.1 | |||||
PRSS1 | ENST00000485223.1 | n.-20_-18delTCC | upstream_gene_variant | 2 | ||||||
PRSS1 | ENST00000497041.1 | n.-29_-27delTCC | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00124 AC: 188AN: 152084Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
188
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000382 AC: 96AN: 251444Hom.: 1 AF XY: 0.000258 AC XY: 35AN XY: 135896
GnomAD3 exomes
AF:
AC:
96
AN:
251444
Hom.:
AF XY:
AC XY:
35
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000192 AC: 280AN: 1461072Hom.: 0 AF XY: 0.000162 AC XY: 118AN XY: 726942
GnomAD4 exome
AF:
AC:
280
AN:
1461072
Hom.:
AF XY:
AC XY:
118
AN XY:
726942
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00124 AC: 189AN: 152202Hom.: 2 Cov.: 32 AF XY: 0.00106 AC XY: 79AN XY: 74408
GnomAD4 genome
AF:
AC:
189
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
79
AN XY:
74408
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary pancreatitis Pathogenic:1Benign:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 1999 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 08, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2022 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Dec 16, 2019 | Variant summary: PRSS1 c.-30_-28delTCC is located in the untranscribed region upstream of the PRSS1 gene region. The variant allele was found at a frequency of 0.00049 in 282842 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 98- fold the estimated maximal expected allele frequency for a pathogenic variant in PRSS1 causing Chronic Pancreatitis phenotype (5e-06), strongly suggesting that the variant is benign. c.-30_-28delTCC has been reported in the literature in at least one individual affected with Chronic Pancreatitis (Ferec_1999) without strong evidence for causality such as cosegregation with disease. This report does not provide unequivocal conclusions about association of the variant with Chronic Pancreatitis. At least one publication reports in vitro experimental evidence evaluating trancription of PRSS1 and found that the variant had no significant impact on PRSS1 transcription in mammalian cells (Boulling_2016). These results showed no damaging effect of this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 23, 2019 | See Variant Classification Assertion Criteria. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at